| Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | AU$ 1.71M | AU$ 1.89M | AU$ 2.32M | AU$ 1.65M | AU$ 7.77M |
| Gross Profit | AU$ -260.31K | AU$ 1.89M | AU$ 2.32M | AU$ 1.37M | AU$ 7.49M |
| Operating Income | AU$ -9.68M | AU$ -8.12M | AU$ -8.81M | AU$ -16.54M | AU$ -6.90M |
| EBITDA | AU$ -9.42M | AU$ -9.33M | AU$ -9.95M | AU$ -15.65M | AU$ -6.00M |
| Net Income | AU$ -9.25M | AU$ -9.39M | AU$ -9.74M | AU$ -14.28M | AU$ -5.45M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | AU$ 897.42K | AU$ 5.05M | AU$ 6.21M | AU$ 16.17M | AU$ 23.80M |
| Total Assets | AU$ 1.35M | AU$ 7.20M | AU$ 8.39M | AU$ 18.99M | AU$ 26.55M |
| Total Debt | AU$ 0.00 | AU$ 0.00 | AU$ 0.00 | AU$ 0.00 | AU$ 0.00 |
| Net Debt | AU$ -897.42K | AU$ -5.05M | AU$ -6.21M | AU$ -16.17M | AU$ -23.80M |
| Total Liabilities | AU$ 1.75M | AU$ 1.22M | AU$ 1.17M | AU$ 2.26M | AU$ 2.59M |
| Stockholders' Equity | AU$ -394.24K | AU$ 5.98M | AU$ 7.22M | AU$ 16.73M | AU$ 23.96M |
| Cash Flow | |||||
| Free Cash Flow | AU$ -6.74M | AU$ -8.77M | AU$ -9.96M | AU$ -14.28M | AU$ -3.30M |
| Operating Cash Flow | AU$ -6.74M | AU$ -8.72M | AU$ -9.96M | AU$ -14.28M | AU$ -3.30M |
| Investing Cash Flow | AU$ 0.00 | AU$ -50.00K | AU$ 0.00 | AU$ 0.00 | AU$ 0.00 |
| Financing Cash Flow | AU$ 2.58M | AU$ 7.61M | AU$ 0.00 | AU$ 6.72M | AU$ 210.12K |
Cynata Therapeutics Limited (CYYNF)
OTHER OTC:CYYNF
